Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.2K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms.

Molecular therapy. Nucleic acids·2026
Same author

The PhNH10-PhDREB1C-PhPOD/Ph3GT module positively regulates cold stress tolerance by scavenging reactive oxygen species in Petunia.

Plant physiology·2026
Same author

Physiological and multi-omics analyses reveal distinct effects of green light and increased silicate supply on cellular fucoxanthin content and fucoxanthin titer in Thalassiosira weissflogii.

Bioresource technology·2026
Same author

The impact of mobile payment on rice farmers' purchasing behavior of new rice varieties: a case study of rice cultivation in Jiangxi Province.

Frontiers in nutrition·2026
Same author

Highly Dissymmetric and Multicolor Circularly Polarized Organic Hyperafterglow.

Angewandte Chemie (International ed. in English)·2026
Same author

A multi-objective optimization framework for planning electric vehicle charging infrastructure incorporating traffic demand, cost, and equity considerations.

Scientific reports·2026

関連する実験動画

Updated: Sep 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

マルチビューコントラスティヴ・ラーニングによる薬物相互作用の予測

Dongxu Li, Feifan Zhao, Yue Yang

    IEEE journal of biomedical and health informatics
    |August 20, 2025
    PubMed
    まとめ

    薬物相互作用 (DDI) を予測することは,患者の安全にとって極めて重要です. 新しいマルチビューコントラスティブ・ラーニング・フレームワーク (MCL-DDI) は,分子およびネットワークデータを用いて複雑なDDIイベントを正確に識別します.

    科学分野:

    • 薬理学と計算化学

    背景:

    • 薬物相互作用 (DDI) は,治療の有効性や患者の安全性に影響を及ぼす重大なリスクをもたらします.
    • パーソナライズド医療と薬の開発には DDI イベントの正確な予測が不可欠です

    研究 の 目的:

    • DDI イベント予測の強化のための新しいマルチビューコントラスティブ ラーニング フレームワークであるMCL-DDIを導入する.
    • 薬物相互作用を特定する際の精度向上のために,多様な薬物表現を活用する.

    主な方法:

    • 統合された分子構造とネットワーク機能により 多視野の薬物表現ができます
    • 異なる視点の表現を一致させ,統一するために,対照的な学習を採用した.
    • DDIイベント予測のためのベンチマークデータセットに関するフレームワークを検証した.

    主要な成果:

    • MCL-DDIは予測精度において 既存の最先端の方法を大幅に上回りました
    • 症例研究では,臨床的に重要なDDIを特定するモデルの能力が示されました.
    • このフレームワークは複雑な相互作用パターンを識別する上で 堅実なパフォーマンスを示した.

    結論:

    • MCL-DDIは,DDIイベント予測のための強力で正確なアプローチを提供します.

    さらに関連する動画

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K

    関連する実験動画

    Last Updated: Sep 10, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.8K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.0K
  • この枠組みは,薬物開発とリスク評価のための実用的な洞察を提供します.
  • この研究は,より安全で効果的な薬理学的介入のパラダイムを前進させています.